チクングニアの市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

チクングニア市場は、2023年に5億2,933万米ドルと評価され、2024年には5億6,511万米ドルに達すると予測され、CAGR 6.89％で成長し、2030年には8億4,397万米ドルに達すると予測されています。

蚊が媒介するウイルス性疾患であるチクングニアは、散発的な発生とそれに伴う衰弱性の関節痛により、公衆衛生上の懸念としてますます認識されるようになっています。この市場調査の対象範囲は、チクングニアの疫学、予防、治療、管理戦略に加え、ワクチンや治療開発のモニタリングも含みます。包括的な市場分析の必要性は、チクングニアがもたらす世界の健康負担にあり、効果的なワクチンや抗ウイルス薬の需要を促進しています。用途と最終用途は、医薬品、ヘルスケア機関、公衆衛生政策の枠組み、ベクターコントロール機構に及びます。主な成長要因としては、認知度の向上、研究に対する政府からの資金援助、蚊の駆除における技術の進歩などが挙げられます。アカイエカが生息する地域が拡大し、熱帯・亜熱帯地域での疾病発生が増加していることから、潜在的な市場機会は拡大しています。しかし、低所得地域における不十分なインフラ、複雑なワクチン開発、デング熱やマラリアなど他の蚊媒介性疾患との競合など、市場開拓には限界があります。

さらに、ワクチン流通における文化的・物流的課題や、新製品に対する一般市民の受容が、市場浸透の妨げになる可能性があります。技術革新と研究の機会は、費用対効果が高くスケーラブルな媒介蚊制御ソリューションの開発、ワクチン試験の進展、症状緩和のための治療介入の改善にあります。蚊の繁殖力やトランスミッションを低下させる遺伝子編集に焦点を当てた調査は、変革をもたらす可能性があります。さらに、早期発見や遠隔医療相談のためのモバイルヘルス技術を開発すれば、疾病管理の効率を高めることができます。チクングニア市場は周期的な需要パターンを示し、しばしば伝染病の流行時に急増し、旅行や気候変動などの要因に影響されることから、適応的な市場戦略の必要性が示唆されます。企業は、地域の保健当局との協力関係や、製品の普及を促進するための啓発プログラムへの投資を活用することができます。研究開発における戦略的パートナーシップは、流行市場と新興国市場の両方に対応し、斬新なソリューションの展開をさらに加速させることができます。

市場力学：急速に進化するチクングニア市場の主要市場インサイトを公開

チクングニア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のチクングニアウイルスの流行増加
  • 規制機関による国際的な保健規制と政策の支持
  • 認知度向上のための政府・非政府イニシアチブの増加
• 市場抑制要因
  • 研究開発に関連する高コスト
• 市場機会
  • チクングニアの診断技術と治療オプションの進歩
  • チクングニアを管理するための遠隔医療サービスの統合
• 市場の課題
  • チクングニアのワクチン開発と製造における複雑さ

ポーターのファイブフォース：チクングニア市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、チクングニア市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：チクングニア市場における外部からの影響の把握

外部マクロ環境要因は、チクングニア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析チクングニア市場における競合情勢の把握

チクングニア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスチクングニア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、チクングニア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨チクングニア市場における成功への道筋を描く

チクングニア市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • チクングニアウイルスの世界の蔓延増加
    • 規制機関による国際的な保健規制と政策の支援
    • 意識を高めるための政府および非政府による取り組みの強化
  • 抑制要因
    • 研究開発にかかるコストの高さ
  • 機会
    • チクングニアの診断技術と治療オプションの進歩
    • 遠隔医療サービスと遠隔医療の統合による管理チクングニア
  • 課題
    • チクングニアのワクチン開発と製造における複雑さ
• 市場セグメンテーション分析
  • タイプ：チクングニアの次世代治療開発に向けた研究開発の強化
  • エンドユーザー：Coolab
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 チクングニアの市場：タイプ別

• 診断
  • 血清学的検査
  • ウイルス検出検査
• 治療

第7章 チクングニアの市場：エンドユーザー別

• 診断センター
• 病院・クリニック
• 調査機関

第8章 南北アメリカのチクングニアの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のチクングニアの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのチクングニアの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • FDAによるIxchiqの承認：リスクの高い成人向けのチクングニアに対する新しいワクチン
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Beckman Coulter, Inc.
• Becton, Dickinson and Company（BD）
• BioMedomics Inc.
• Cellex, Inc.
• Chembio Diagnostic Systems, Inc. by Biosynex
• Creative Diagnostics
• ELITechGroup by Bruker Corporation
• Eurofins Scientific Ltd.
• F. Hoffmann La-Roche Ltd
• Grifols Diagnostic Solutions Inc.
• Immucor, Inc.
• Quest Diagnostics
• Randox Laboratories Ltd.
• Serological Research Institutes
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. CHIKUNGUNYA MARKET RESEARCH PROCESS
• FIGURE 2. CHIKUNGUNYA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CHIKUNGUNYA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CHIKUNGUNYA MARKET DYNAMICS
• TABLE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CHIKUNGUNYA MARKET SIZE, BY VIRAL DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CHIKUNGUNYA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CHIKUNGUNYA MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 27. CANADA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 44. CHINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 47. INDIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 99. ITALY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 111. POLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 114. QATAR CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 144. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023

The Chikungunya Market was valued at USD 529.33 million in 2023, expected to reach USD 565.11 million in 2024, and is projected to grow at a CAGR of 6.89%, to USD 843.97 million by 2030.

Chikungunya, a mosquito-borne viral disease, has been increasingly recognized as a public health concern due to sporadic outbreaks and its associated debilitating joint pain. The scope of this market research encompasses the epidemiology, prevention, treatment, and management strategies for chikungunya, alongside monitoring vaccine and therapeutic developments. The necessity for comprehensive market analysis lies in the global health burden posed by chikungunya, driving demand for effective vaccines and anti-viral drugs. Application and end-use span across pharmaceuticals, healthcare institutions, public health policy frameworks, and vector control mechanisms. Key growth influencers include rising awareness, government funding for research, and technological advancements in mosquito control. The potential market opportunity is magnified by the expanding geographic range of Aedes mosquitoes and increasing incidences of disease outbreaks in tropical and subtropical regions. However, market growth faces limitations such as insufficient infrastructure in low-income regions, the complexities of vaccine development, and competition with other mosquito-borne disease priorities like dengue and malaria.

Moreover, cultural and logistical challenges in vaccine distribution and public acceptance of new products may hinder market penetration. Opportunities for innovation and research lie in developing cost-effective and scalable vector control solutions, advancing vaccine trials, and improving therapeutic interventions to alleviate symptoms. Research focusing on genetic editing to reduce mosquito fertility or transmissibility could be transformative. Furthermore, creating mobile health technologies for early detection and telemedicine consultations can augment disease management efficiency. The chikungunya market exhibits cyclic demand patterns, often spiking during outbreaks, and is influenced by factors like travel and climate change, suggesting a need for adaptive market strategies. Businesses can capitalize on collaborations with local health authorities and investing in awareness programs to enhance product uptake. Strategic partnerships in research and development can further accelerate novel solution rollouts, catering to both endemic and emergent markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chikungunya Market

The Chikungunya Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased prevalence of chikungunya virus globally
  • Supportive international health regulations and policies by regulatory bodies
  • Increasing government and non-government initiatives to raise awareness
• Market Restraints
  • High costs associated with research and development
• Market Opportunities
  • Advancements in diagnostic techniques and treatment options for Chikungunya
  • Integration of telemedicine services for remote care to manage Chikungunya
• Market Challenges
  • Complexities in vaccine development and manufacturing for Chikungunya

Porter's Five Forces: A Strategic Tool for Navigating the Chikungunya Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chikungunya Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chikungunya Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chikungunya Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chikungunya Market

A detailed market share analysis in the Chikungunya Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chikungunya Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chikungunya Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chikungunya Market

A strategic analysis of the Chikungunya Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chikungunya Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BioMedomics Inc., Cellex, Inc., Chembio Diagnostic Systems, Inc. by Biosynex, Creative Diagnostics, ELITechGroup by Bruker Corporation, Eurofins Scientific Ltd., F. Hoffmann La-Roche Ltd, Grifols Diagnostic Solutions Inc., Immucor, Inc., Quest Diagnostics, Randox Laboratories Ltd., Serological Research Institutes, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Chikungunya Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diagnosis and Treatment. The Diagnosis is further studied across Serological Tests and Viral Detection Tests.
• Based on End-Users, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased prevalence of chikungunya virus globally
    • 5.1.1.2. Supportive international health regulations and policies by regulatory bodies
    • 5.1.1.3. Increasing government and non-government initiatives to raise awareness
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with research and development
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in diagnostic techniques and treatment options for Chikungunya
    • 5.1.3.2. Integration of telemedicine services for remote care to manage Chikungunya
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in vaccine development and manufacturing for Chikungunya
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising R&D toward development of next generation treatment for chikungunya
  • 5.2.2. End-Users: Coolab
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Chikungunya Market, by Type

• 6.1. Introduction
• 6.2. Diagnosis
  • 6.2.1. Serological Tests
  • 6.2.2. Viral Detection Tests
• 6.3. Treatment

7. Chikungunya Market, by End-Users

• 7.1. Introduction
• 7.2. Diagnostic Centers
• 7.3. Hospitals & Clinics
• 7.4. Research Institutions

8. Americas Chikungunya Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Chikungunya Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Chikungunya Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. FDA Approval of Ixchiq: A New Vaccine Against Chikungunya for High-Risk Adults
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Beckman Coulter, Inc.
• 3. Becton, Dickinson and Company (BD)
• 4. BioMedomics Inc.
• 5. Cellex, Inc.
• 6. Chembio Diagnostic Systems, Inc. by Biosynex
• 7. Creative Diagnostics
• 8. ELITechGroup by Bruker Corporation
• 9. Eurofins Scientific Ltd.
• 10. F. Hoffmann La-Roche Ltd
• 11. Grifols Diagnostic Solutions Inc.
• 12. Immucor, Inc.
• 13. Quest Diagnostics
• 14. Randox Laboratories Ltd.
• 15. Serological Research Institutes
• 16. Thermo Fisher Scientific, Inc.